Evidence map›Paper›PMID 28778848›Full record

ArticleJMIR research protocols2017

A Web-Based Public Health Intervention to Reduce Functional Impairment and Depressive Symptoms in Adults With Type 2 Diabetes (The SpringboarD Trial): Randomized Controlled Trial Protocol.

Judy Proudfoot, Janine Clarke, Jane Gunn, Susan Fletcher, Samineh Sanatkar, Kay Wilhelm, Lesley Campbell, Nicholas Zwar, Mark Harris, Helen Lapsley and 2 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Judy Proudfoot *Black Dog Institute, Randwick, Australia.ORCID http://orcid.org/0000-0002-3872-9871
Janine Clarke *Black Dog Institute, Randwick, Australia.ORCID http://orcid.org/0000-0002-2652-5273
Jane Gunn *Department of General Practice, University of Melbourne, Melbourne, Australia.ORCID http://orcid.org/0000-0001-8836-7525
Susan Fletcher *Department of General Practice, University of Melbourne, Melbourne, Australia.ORCID http://orcid.org/0000-0001-6359-8650
Samineh SanatkarBlack Dog Institute, Randwick, Australia.ORCID http://orcid.org/0000-0001-9962-163X
Kay WilhelmSchool of Psychiatry, University of New South Wales (UNSW) Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0002-8542-6478
Lesley CampbellDiabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, Australia.ORCID http://orcid.org/0000-0001-7775-0246
Nicholas ZwarSchool of Medicine, University of Wollongong, Wollongong, Australia.ORCID http://orcid.org/0000-0001-6462-9121
Mark HarrisCentre for Primary Health Care and Equity, University of New South Wales (UNSW) Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0002-0783-7394
Helen LapsleySchool of Psychiatry, University of New South Wales (UNSW) Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0002-3376-7131
Dusan Hadzi-PavlovicSchool of Psychiatry, University of New South Wales (UNSW) Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0002-2059-3865
Helen ChristensenBlack Dog Institute, Randwick, Australia.ORCID http://orcid.org/0000-0003-0435-2065
Black Dog Institute · AUUNSW Sydney · AUThe University of Melbourne · AUGarvan Institute of Medical Research · AUUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepressive symptoms are common in people with type 2 diabetes and contribute to adverse health consequences that substantially impact social and vocational function. Despite the existence of effective depression treatments, the majority of people with type 2 diabetes do not access these when needed. Web-based alternatives to more traditional psychotherapies offer a potential solution to reducing the personal and economic burdens of type 2 diabetes.

objectiveThis paper outlines the protocol for a randomized controlled trial (RCT) of myCompass, a Web-based public health psychotherapy intervention, in people with type 2 diabetes. Fully automated, interactive, and delivered via the Internet without clinician support, myCompass teaches cognitive behavioral therapy-based skills and supports symptom monitoring to improve daily functioning and reduce mild-to-moderate mental health symptoms.

methodsA two-arm RCT will be conducted. People with type 2 diabetes and mild-to-moderately severe depressive symptoms will be recruited from the community and general practice settings. Screening and enrollment is via an open-access website. Participants will be randomized to use either myCompass or an active placebo program for 8 weeks, followed by a 4-week tailing-off period. The placebo program is matched to myCompass on mode of delivery, interactivity, and duration. Outcomes will be assessed at baseline and at 3-month, 6-month, and 12-month follow-up. The primary study outcome is work and social functioning. Secondary study outcomes include depressive and anxious symptoms, diabetes-related distress, self-care behaviors, and glycemic control.

resultsNationwide recruitment is currently underway with the aim of recruiting 600 people with type 2 diabetes. Recruitment will continue until October 2017.

conclusionsThis is the first known trial of a Web-based psychotherapy program that is not diabetes specific for improving social and vocational function in people with type 2 diabetes and mild-to-moderately severe depressive symptoms. With the increasing prevalence of type 2 diabetes and depression, a potentially scalable public health intervention could play a very large role in reducing unmet mental health need and ameliorating the personal and societal impact of illness comorbidity.

trial registrationAustralian New Zealand Clinical Trials Registry (ANZCTR) Number: ACTRN12615000931572; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=368109 (Archived by WebCite at http://www.webcitation.org/ 6rh3imVMh).

Indexed as

depressiontype 2 diabetesWeb-based intervention

Identifiers

PMID28778848
PMCPMC5561386
OpenAlexW2741550754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.